Online Program

276966
Coronary artery disease in women with and without rheumatoid arthritis in Kentucky women's health registry


Tuesday, November 5, 2013 : 8:50 a.m. - 9:10 a.m.

Hassan Mousa, Epidemiology, University of Kentucky -College of Public Health, Lexington, KY
Abstract: I will use the data from the Kentucky Women's Health Registry To compare the incidence of coronary artery disease (CAD) in women with rheumatoid arthritis (RA) with that in women without RA, adjusting for traditional CAD risk factors (age, smoking, race, diabetes mellitus, hypercholesterolemia, hypertension, physical inactivity, family history, and obesity). A logistic regression analysis will be used to control for confounders and other variables. I will determine how many women with rheumatoid arthritis and how many women without rheumatoid arthritis. Incidence rate of CAD will be measured in both groups. Data analysis will be limited to all women who participated in the 2010 survey and of the 7844 who completed the 2010 Women's Health Survey, 7338 (93.5%) participants did not have rheumatoid arthritis, 310 (3.9%) have rheumatoid arthritis, and 196 (2.4%) were missing >

Learning Areas:

Chronic disease management and prevention
Clinical medicine applied in public health
Epidemiology
Public health or related education
Public health or related laws, regulations, standards, or guidelines
Public health or related research

Learning Objectives:
Compare the incidence rate of coronary artery disease in women with rheumatoid arthritis and without rheumatoid arthritis in the Kentucky Women’s Health Registry.

Keyword(s): Arthritis, Heart Disease

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I’m doing MPH at the University of Kentucky. I finished the core and the optional credits, now I’m working on my thesis under supervision of Dr. Mannino, he is my advisor. My concentration is epidemiology, I’m interested in cardiac diseases researches.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.